South Korean medical AI company Lunit and Canada-based research organisation CellCarta have partnered to integrate digital ...

ROCKVILLE, Md. – June 24, 2025 – The Association for Molecular Pathology, the premier global molecular diagnostic professional society, today announced the publication of best practice recommendations ...

The Ecosystem for Pathology Diagnostics with AI Assistance (EMPAIA), an international organization that advances the use of ...

CHICAGO--(BUSINESS WIRE)--Nucleai, a leading provider of artificial intelligence (AI) solutions for pathology and spatial biology, and Mayo Clinic BioPharma Diagnostics are pleased to announce a ...

A multi-institutional study from the Accelerating GBM Therapies Through Serial Biopsies TeamLab, led by investigators from ...

C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, is ...

At ASTRO, Artera presented clinical validation data on its prostate cancer test in an Asian population,and showed how the test may complement gene expression-based approaches.

In early studies, artificial intelligence (AI) has demonstrated promise toward supporting and augmenting clinician-driven cancer diagnosis and prognosis; an example includes the emergence of digital ...

New technologies emerging from the Human Genome Project and the rapidly expanding direct-to-consumer DNA testing have provided a challenging environment for the entry of pharmacogenomics into clinical ...

Dr. B was not about to wait for his office manager to inform him that yet another clinical practice was sending its pathology work elsewhere. Last year, his group had lost the business of both a ...